Introduction
Carbapenems have a potent activity against Acinetobacter and are often used as a last resort for the treatment of infections due to multi-resistant Acinetobacter baumannii isolates. 1 However, A.
baumannii may develop resistance to carbapenems through various combined mechanisms, including decreased permeability, altered penicillin binding proteins (PBPs) and, rarely, efflux pump overexpression. 2 The most frequent mechanism of resistance is through the production of class D oxacillinases (OXA). The intrinsic bla OXA-51-like and the acquired bla OXA genes (23-like, 40-like, 58-like, and 143) are often associated with insertion elements that are thought to upregulate expression. 3 Less common are class B IMPand VIM-type metallo-b-lactamases (MBLs). 4 Recently an increase in the prevalence of carbapenem-resistant A. baumannii isolates has been observed at the Clinical Hospital Center Zagreb. The aim of this study was to characterize the mechanisms of carbapenem resistance in our A. baumannii isolates and their molecular epidemiology.
Materials and methods

Bacterial isolates
Thirty-four non-duplicate A. baumannii isolates (one isolate per patient) with reduced susceptibility to imipenem and meropenem by disk diffusion (zone diameter 16 mm) were collected between July and October 2008 from various clinical specimens and hospital units (Table 1) .
Background: From July to October 2008, 34 Acinetobacter baumannii isolates were involved in an outbreak at the Clinical Hospital Center, Zagreb. The aim of this study was to characterize the mechanisms of carbapenem resistance in our A. baumannii isolates and determine their epidemiology. Methods: Antibiotic susceptibilities were determined by broth microdilution. PCR was used to detect the presence of carbapenemases. Genotyping of the isolates was performed by random amplification of polymorphic DNA (RAPD), pulsed-field gel electrophoresis (PFGE), and repetitive sequence-based PCR (rep-PCR). Results: Thirty-three carbapenem-resistant isolates were positive for the acquired bla OXA-72 and one unrelated isolate was positive for bla OXA-58 . The bla OXA-72 -positive isolates were shown to be clonally related by RAPD, rep-PCR, and PFGE.
Conclusions: On the basis of susceptibility testing, b-lactamase characterization, and genotyping of the isolates we can conclude that clonal spread of endemic isolates was responsible for the high frequency of OXA-72-positive multidrug-resistant A. baumannii in this setting. Most of the isolates originated from the intensive care unit indicating local dissemination within the hospital and pointing to the potential source of isolates.
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Clinical and Laboratory Standards Institute (CLSI) guidelines. 6 Pseudomonas aeruginosa ATCC 27853 was used as the quality control strain.
Detection of metallo-b-lactamases
Etest MBL strips were used for the detection of metallocarbapenemases following the manufacturer's instructions (AB Biodisk, Solna, Sweden). Furthermore, the isolates were tested by synergy test using imipenem and ethylenediaminetetraacetic acid (EDTA)-containing disks to screen for metallo-b-lactamase production. 7 
Characterization of b-lactamases
PCR was used to detect the presence of the genes encoding metallo-b-lactamases, OXA-encoding genes, and bla TEM genes as previously described. [8] [9] [10] The genetic context of bla OXA-40-like and bla OXA-58-like genes was determined by PCR mapping using ISAbaI and ISAbaIII primers. 11, 12 Partial sequences of selected bla OXA-51-like , bla OXA-40-like , and bla OXA-58-like genes were determined. To determine if acquired oxacillinase genes were plasmidencoded, plasmid DNA was extracted using the QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany) and transferred to A. baumannii ATCC 19606 recipient isolate by electroporation.
Transformants were selected on 100 mg/ml ticarcillin. In addition, plasmid DNA was used as template for PCR for the detection of bla OXA-40 and bla OXA-58 genes.
Genotyping of the isolates
All A. baumannii isolates were initially genotyped by random amplification of polymorphic DNA (RAPD) using M13 primer. 13 Sequence groups (1-3) corresponding to EU clones I-III were determined by multiplex PCR as described previously.
14 Representative isolates were further investigated by repetitive sequencebased PCR (rep-PCR) (DiversiLab System; bioMé rieux, Nurtingen, Germany) following the manufacturer's instructions. Isolates that clustered above 95% were considered related. 15 Pulsed-field gel electrophoresis (PFGE) genotyping of XbaI-digested genomic DNA was performed with a CHEF-DRIII system (Bio-Rad, Zagreb, Croatia), 16 the images were processed using Gel-Compar software, and a dendrogram was computed after band intensity correlation using global alignment with 1.5% optimization and UPGMA (unweighted pair group method with arithmetic mean) clustering. 17, 18 3. Results
Antimicrobial susceptibility
MIC data are summarized in Table 1 . All isolates were uniformly resistant to ceftazidime, cefotaxime, ceftriaxone, piperacillin/ (Table  1) . Electroporation experiments using plasmid extracts from bla OXA-72 -and bla OXA-58 -positive isolates were unsuccessful in transferring carbapenem resistance to electrocompetent A. baumannii ATCC 19606. Plasmid bands were not visible after electrophoresis of plasmid DNA and these plasmid preparations were negative for bla . Partial sequencing of the bla OXA-51-like genes revealed that the bla OXA-72 isolates possessed bla OXA-66/76 . These genes differ at nucleotide 808, which was not covered by the sequencing reaction. The bla OXA-58 isolate possessed bla OXA-68 (Table 1) .
Genotyping of the isolates
The OXA-72 producers belonged to EU clone 2, which is in agreement with possession of bla OXA-66/76 (sequence group I). The OXA-58 strain did not cluster with any of the European clones. RAPD analysis grouped the OXA-72 isolates together, and these isolates showed identical banding patterns in rep-PCR (Figure 1) . The OXA-58 isolate was distinct. PFGE confirmed the clonality of the predominant A. baumannii bla OXA-72 -positive isolates.
Discussion
Previously in Croatia, carbapenem resistance was associated with upregulation of the bla OXA-51 gene by ISAbaI. 19 This study found OXA-72, a member of the OXA-40 subclass, to be the most prevalent carbapenem resistance determinant among our A. baumannii isolates, and this represents the first report of 24 South Korea, 25 Taiwan, 26 China, 27 and Brazil. 28 In contrast to our results, they proved the plasmid location of bla OXA-72 gene. The isolates displayed high MICs for carbapenems, which could also be attributed to other resistance mechanisms, such as porin loss or upregulated efflux pumps, 2,3 but clarification of these additional resistance mechanisms was beyond the scope of this study. Resistance to ampicillin/sulbactam is worrying and was most likely due to the production of TEM b-lactamases. 22 Colistin became the antibiotic of choice for the treatment of infections caused by our A. baumannii isolates, as this was the only antimicrobial to have activity. However, the risk of nephrotoxicity is of clinical concern. Tigecycline has been shown to be effective in vitro and in vivo against multidrug-resistant A. baumannii, 29 but is not yet licensed in Croatia. The combination of tigecycline, colistin, and meropenem has been shown to yield a favorable clinical outcome against multi-resistant A. baumannii.
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In conclusion, this study highlights the propensity of clonal spread of multidrug-resistant A. baumannii, in particular carbapenem-resistant isolates. Furthermore, the factors responsible for dissemination of such isolates need to be identified, controlled, and prevented to avoid major outbreaks. 
